Amanote Research
Register
Sign In
Biologic Treatments for Rheumatoid Arthritis
Trends in Urology & Men's Health
doi 10.1002/tre.711
Full Text
Open PDF
Abstract
Available in
full text
Date
September 1, 2019
Authors
Jalpa B Kotecha
Patrick DW Kiely
Publisher
Wiley
Related search
Characteristics of Patients Starting Biologic Treatments for Rheumatoid Arthritis in the Real World: Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Biologic Refractory Disease in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Persistence With Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan
Patient Preference and Adherence
Pharmacology
Health Policy
Medicine
Toxicology
Social Sciences
Pharmaceutics
Factors Determining Long-Term Success of Biologic Therapy in Rheumatoid Arthritis
Modern Rheumatology Journal
Biologic Monotherapy in the Biologic Naïve Patient With Rheumatoid Arthritis (RA): Results From an Observational Study
Rheumatology International
Rheumatology
Allergy
Immunology
Unmet Needs and Biologic Use Among Patients With Rheumatoid Arthritis in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Selected Problems of Biologic Therapy in Rheumatoid Arthritis Patients – Pregnancy During Therapy.
Reumatologia
Rheumatology
Allergy
Immunology
SAT0200 Biologic Therapy Retention in Rheumatoid Arthritis (RA) Patients (PTS) According to the Moscow Arthritis Registry (MAR)
